0000899243-20-020385.txt : 20200724 0000899243-20-020385.hdr.sgml : 20200724 20200724164052 ACCESSION NUMBER: 0000899243-20-020385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200722 FILED AS OF DATE: 20200724 DATE AS OF CHANGE: 20200724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norkunas Matthew CENTRAL INDEX KEY: 0001816836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 201047313 MAIL ADDRESS: STREET 1: C/O GENERATION BIO CO. STREET 2: 301 BINNEY STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-22 0 0001733294 Generation Bio Co. GBIO 0001816836 Norkunas Matthew C/O GENERATION BIO CO., 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 21.41 2020-07-22 4 A 0 330000 0.00 A 2030-07-21 Common Stock 330000 330000 D The option was granted on July 22, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on July 22, 2021 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Jennifer Elliott, Attorney-in-Fact 2020-07-24